Lung Cancer

Informed consent forms for interventional oncology clinical trials are often lengthy and written at too high of a reading level for some patients, making it hard for them to weigh the decision to participate, according to study results.

Younger adults with lung cancer had a higher likelihood of having late-stage disease at diagnosis than older adults, according to study results.

About 15% of a large cohort of patients with lung cancer had pathogenic germline variants, nearly all of which could be clinically actionable, according to study results presented during an ASCO Plenary Series session.

Sublobar resection conferred similar survival outcomes as lobectomy among certain patients with non-small cell lung cancer, according to phase 3 study results.

Most women with lung cancer reported some degree of sexual dysfunction following diagnosis, according to study results presented during International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Researchers at New York University, Weill Cornell Medicine and New York Genome Center have developed and tested a two-step approach that uses whole-exome sequencing to find genes and pathways that predict response to immunotherapy.

A randomized phase 3 trial designed to evaluate canakinumab as adjuvant treatment for completely resected non-small cell lung cancer failed to meet its primary endpoint, according to the agent’s manufacturer.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for treatment of adults with HER2-mutated unresectable or metastatic non-small cell lung cancer.

The FDA approved capmatinib for treatment of certain adults with metastatic non-small cell lung cancer.

In this edition, lung cancer risk is high among smokers for whom screening is not recommended; the role of circulating tumor DNA in lung cancer detection and treatment is 'exciting' for field; a subset of patients with lung cancer have poor response to COVID-19 vaccines, and more.